← All themes

Immunotherapy & Oncology

Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.

388 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
326	GRCL 326 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
327	327 DELISTED Gritstone bio, Inc. Common Stock GRTS	–	–	–	–
328	328 DELISTED G1 Therapeutics, Inc. Common Stock GTHX	–	–	–	–
329	HARP 329 DELISTED Harpoon Therapeutics, Inc. Common Stock HARP	–	–	–	–
330	HGEN 330 DELISTED HUMANIGEN, INC. HGEN	–	–	–	–
331	HHJ 331 DELISTED HEALTHSHARES EMERGING CANCER INDEX FUND HHJ	–	–	–	–
332	HHK 332 DELISTED HEALTHSHARES INC CANCER INDEX FD HHK	–	–	–	–
333	333 DELISTED HOOKIPA Pharma HOOK	–	–	–	–
334	334 DELISTED IGM Biosciences IGMS	–	–	–	–
335	IMGO 335 DELISTED Imago BioSciences, Inc. Common stock IMGO	–	–	–	–
336	IMV 336 DELISTED IMV Inc. Common Shares IMV	–	–	–	–
337	337 DELISTED Inhibrx, Inc. Common Stock INBX	–	–	–	–
338	INFI 338 DELISTED Infinity Pharmaceuticals, Inc. INFI	–	–	–	–
339	339 DELISTED iTeos Therapeutics ITOS	–	–	–	–
340	JNCE 340 DELISTED Jounce Therapeutics, Inc. Common Stock JNCE	–	–	–	–
341	341 DELISTED Kineta, Inc. Common Stock KA	–	–	–	–
342	KNTE 342 DELISTED Kinnate Biopharma Inc. Common Stock KNTE	–	–	–	–
343	KRBP 343 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
344	344 DELISTED Kronos Bio KRON	–	–	–	–
345	345 DELISTED Lumos Pharma, Inc. Common Stock LUMO	–	–	–	–
346	346 DELISTED LAVA Therapeutics LVTX	–	–	–	–
347	MDNA 347 DELISTED Medicenna Therapeutics Corp. Common Shares MDNA	–	–	–	–
348	348 DELISTED MorphoSys AG American Depositary Shares MOR	–	–	–	–
349	MRTX 349 DELISTED Mirati Therapeutics, Inc. Common Stock MRTX	–	–	–	–
350	350 DELISTED Molecular Templates, Inc. MTEM	–	–	–	–